Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Symrise adds probiotics to portfolio with Probi stake

1 commentBy Shane Starling , 31-Aug-2012
Last updated on 31-Aug-2012 at 18:59 GMT2012-08-31T18:59:12Z

Symrise adds probiotics to portfolio with Probi stake

The CEO of Swedish probiotics specialist Probi says the 11.8% stake taken by German flavours, fragrances and nutrients house Symrise will give it, “more marketing and R&D muscle”.

While the undisclosed transaction – which makes Symrise Probi’s largest investor – is purely financial at this stage, Probi CEO Michael Oredsson said the two firms would be sitting down to discuss how they can jointly drive commercial projects.

“They have a global sales force and a lot of R&D expertise so we will look at how to leverage that,” Oredsson told us. “So they definitely bring more marketing and R&D muscle to the table.”

Symrise spokesperson Bernhard Kott said aggressive Symrise had evaluated probiotic firms for some time before choosing to invest in Probi because of its probiotic strain portfolio and the fact it was, “a very well-managed company”.

“This is our first venture into probiotics so this deal is all about complementary competencies and while not defined yet, we are looking to leverage those competencies. It’s a very interesting playing field, the probiotics sector.”

He said Symrise may have become Probi’s biggest shareholder but the German firm had no intention to influence business decisions at board level.

Probi is listed on the Nasdaq OMX Nordic Exchange in Stockholm.

Symrise’s stake consisted of 1,102,301 shares or 11.8 % of the capital and 12.1 % of the voting rights.

Kott said sector expansion was in the firm’s DNA and that further investments and acquisitions were planned.

Symrise is the world’s fourth largest supplier of fragrances and flavourings after Givaudan, Firmenich and International Flavors and Fragrances. It operates in 160 countries and had a turnover of €1.6bn in 2011.

Probi had sales of more than €10m in 2011 and has deals with Danone and Merck.

1 comment (Comments are now closed)

Blis Technologies

Blis Technologies in New Zealand has announced share issue. It's a listed company on New Zealand Stock Exchange.

Report abuse

Posted by Paul
01 September 2012 | 07h192012-09-01T07:19:08Z

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars